e research , published in today ’ s issue of the new england journal of medicine , comes nine years after the u.s. food and drug administration warned that exposure to selective serotonin reuptake inhibitors — the most commonly prescribed antidepressants — might increase the risk of heart malformations in the developing fetus . story_separator_special_tag however , this latest study contradicts previous research that found that taking antidepressants in pregnancy can be risky . newline_char a total of almost a million women who had given birth were included in the study . newline_char it 's diagnosed in 10 percent to 20 percent of pregnant women , and up to 13 percent of women take antidepressants while pregnant , according to the researchers . newline_char wednesday , june 18 , 2014 ( healthday news ) -- antidepressants taken during the first three months of pregnancy do n't appear to increase the risk of heart defects in babies , new research suggests . newline_char the current study 's findings run counter to two previous studies that caused the u.s. food and drug administration in 2005 to formally warn health care professionals that early prenatal exposure to paroxetine ( paxil ) may increase the risk of heart malformations at birth . story_separator_special_tag the reference group consisted of women without exposure to antidepressants during the first trimester . newline_char data source and study cohort the study cohort was drawn from the medicaid analytic extract for 46 u.s. states and washington , d.c. newline_char antidepressant medications the etiologically relevant window for exposure extended from the date of the last menstrual period through day 90 of pregnancy ( first trimester ) . newline_char the development of our study cohort has been described previously.22 briefly , we identified all completed pregnancies in women and adolescents 12 to 55 years of age ( hereafter , “ women ” ) and linked these pregnancies to liveborn infants .
